510(k) K972986
K972986 is an FDA 510(k) premarket notification submitted by Boston Biomedica, Inc. for the device "ACCURUN 140 RUBELLA IGG POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on Oct 8, 1997. The device falls under product code MJX (Kit, Serological, Positive Control), a Class I device regulated under 21 CFR 862.1660. Boston Biomedica, Inc. has 11 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 8, 1997
- Date Received
- Aug 11, 1997
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Kit, Serological, Positive Control
- Device Class
- Class I
- Regulation Number
- 862.1660
- Review Panel
- MI
- Submission Type
- 510(k) Exempt
Need the full FDA record for Boston Biomedica, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.